Prevalence of diabetes mellitus among obese and non-obese patients with coronary artery disease.

Background: Globally, obesity is now recognised as an epidemic. The degree of obesity is proportional to the rate of development of cardiovascular diseases, hence, resulting in a dramatic increase in morbidity and mortality. Apart from obesity, diabetes mellitus is another well recognised risk factor contributing to coronary artery disease.

Frequency of pericardial effusion in patients with first myocardial infarction and its effects on in-hospital morbidity and mortality.

Background: Pericardial effusion (PE) is not an uncommon finding in serial echocardiographic evaluation of patients with AMI, especially when infarction is anterior and extensive. The objective of this study was to determine the frequency of pericardial effusion after first myocardial infarction and its effects on in-hospital morbidity and mortality.

Methods: This descriptive study was performed in the Department of Cardiology, PGMI, LRH Peshawar, from July 2007 to December 2007.

Prevalence of hypertension among obese and non-obese patients with coronary artery disease.

Background: Globally, obesity is now recognised as an epidemic. The degree of obesity is proportional to the rate of development of cardiovascular diseases, hence, resulting in a dramatic increase in morbidity and mortality. Apart from obesity, hypertension is another well recognised risk factor contributing to coronary artery disease (CAD).

Plasma free amino acid levels during the initial rehabilitation of protein-energy malnutrtion with protracted diarrhoea using a free amino acid--glucose diet.

This study intends to assess, by ion-exchange chromatography of free amino acid levels of peripheral blood plasma, the amino acid absorption of severely growth retarded infants with protracted diarrhoea, during the initial period of rehabilitation. Eleven infants from a very low socio-economic group of a developing country, with nutritional marasmic growth retardation and prolonged diarrhoea, were treated for a period of 10 days with a commercially available free amino acid--glucose diet (Vivonex, Pfrimmer Co., Erlangen, Germany).